Osaic Holdings
BMY.RT

Osaic Holdings’s Bristol-Myers Squibb Company Contingent Value Rights BMY.RT Stock Holding History

Osaic Holdings’s Portfolio BMY.RT Stock Details BMY.RT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-46,153
Closed -$30K – 7133
2020
Q4 		$30K Sell
46,153
-9,872
-18% -$21K ﹤0.01% 4927
2020
Q3 		$126K Buy
56,025
+5,867
+12% +$16.8K ﹤0.01% 3628
2020
Q2 		$179K Sell
50,158
-451
-0.9% -$1.63K ﹤0.01% 3231
2020
Q1 		$191K Buy
+50,609
New +$167K ﹤0.01% 2906

Other funds holding BMY.RT

JCI
Jet Capital Investors New York $51M AUM 48.01% 1-Year Est. Return
Tudor Investment Corp
Tudor Investment Corp Stamford, Connecticut $53.9B AUM 29.12% 1-Year Est. Return
BC
Brookfield Corp Toronto, Ontario, Canada $74.2B AUM 0.68% 1-Year Est. Return
TNB
Thomasville National Bank Thomasville, Georgia $1.61B AUM 22.15% 1-Year Est. Return
WAM
Westport Asset Management Southport, Connecticut $226M AUM 16.76% 1-Year Est. Return
IAIM
International Assets Investment Management Orlando, Florida $1.44B AUM 21.92% 1-Year Est. Return

Osaic Holdings's BMY.RT Position: Q1 2021 in Review

Osaic Holdings sold out of Bristol-Myers Squibb Company Contingent Value Rights (BMY.RT) in Q1 2021, closing a stake of 46,153 shares — an estimated $30K sold.

Osaic Holdings first reported a position in BMY.RT in Q1 2020 and held it in 4 quarters. The position peaked at $191K in Q1 2020. 12 funds tracked by Wall St. Rank hold BMY.RT as of Q1 2021.

  • Osaic Holdings reported no remaining Bristol-Myers Squibb Company Contingent Value Rights position as of Q1 2021 after selling out during the quarter.
  • Osaic Holdings sold 46,153 Bristol-Myers Squibb Company Contingent Value Rights shares in Q1 2021, an estimated $30K.
  • Osaic Holdings first reported a position in Bristol-Myers Squibb Company Contingent Value Rights in Q1 2020 and held it in 4 quarters.
  • Osaic Holdings's Bristol-Myers Squibb Company Contingent Value Rights position peaked at $191K in Q1 2020.
  • 12 funds tracked by Wall St. Rank held Bristol-Myers Squibb Company Contingent Value Rights as of Q1 2021.

Based on Osaic Holdings's 13F filing for Q1 2021, filed 13 May 2021.